The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Sphingosine 1-phosphate antagonizes human neutrophil apoptosis via p38 mitogen-activated protein kinase.

På svenska

Author

Summary, in English

Sphingosine 1-phosphate (SPP) is associated with the regulation of apoptosis, although its role in neutrophil apoptosis remains poorly investigated. Here, we show that exogenous SPP antagonizes spontaneous and anti-Fas-induced apoptosis in neutrophils. Pre-treatment with pertussis toxin clearly reduced the apoptosis-inhibiting capacity of SPP. Consequently, we investigated the involvement of potential modulators of apoptosis that are activated downstream of Gi/G0-coupled receptors. Neither Akt activity nor change in basal activity of c-Jun N-terminal kinases was detected during apoptosis or after adding SPP. In contrast, there was a transient decrease in phosphorylation of both extracellular-regulated kinase (ERK) and p38mitogen-activated protein kinase (MAPK) during both spontaneous and anti-Fas-induced apoptosis. Although exogenous SPP reversed these reductions in kinase activity, experiments with inhibitors of ERK (PD98059) and p38 MAPK (SB203580) revealed that only SB203580 counteracted the effect of SPP. Thus, SPP counteracts neutrophil apoptosis via a Gi/G0protein survival-signalling pathway that includes modulation of p38 MAPK activity.

Publishing year

2003

Language

English

Pages

776-785

Publication/Series

Cellular and Molecular Life Sciences

Volume

60

Issue

4

Document type

Journal article

Publisher

Birkhäuser Verlag

Topic

  • Cell Biology

Keywords

  • Neutrophils: physiology
  • Apoptosis: drug effects
  • Apoptosis: physiology
  • Enzyme Inhibitors: pharmacology
  • Flavones: pharmacology
  • Human
  • Imidazoles: pharmacology
  • Mitogen-Activated Protein Kinases: antagonists & inhibitors
  • Mitogen-Activated Protein Kinases: metabolism
  • Phosphorylation
  • Pyridines: pharmacology
  • Signal Transduction: physiology
  • Sphingosine: analogs & derivatives
  • Sphingosine: metabolism
  • Support
  • Non-U.S. Gov't

Status

Published

Research group

  • Experimental Pathology, Malmö
  • Molecular Pathology, Malmö

ISBN/ISSN/Other

  • ISSN: 1420-9071